Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026)
Ptc Therapeutics' (PTCT) quarterly FCF Margin came in at 22.1% in Q1 2026, down 9594.0% year-on-year from 0.23% in Q1 2025, and down 30.39% quarter-over-quarter from 16.95% in Q4 2025.
Ptc Therapeutics (PTCT) FCF Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' FCF Margin history runs 15 years deep, the most recent figure standing at 22.1% for Q1 2026.
- On a quarterly basis, FCF Margin fell 9594.0% year-over-year to 22.1% in Q1 2026; TTM through Mar 2026 was 26.3%, a 7040.0% decrease from a year earlier, with the FY2025 full-year figure at 41.09%, up 5444.0% from the prior year.
- FCF Margin slipped to 22.1% in Q1 2026 per PTCT's latest filing, from 16.95% in the prior quarter.
- Across five years, FCF Margin topped out at 73.84% in Q1 2025 and bottomed at 85.34% in Q4 2022.
- The 5-year median for FCF Margin is 21.05% (2026), against an average of 21.45%.
- Across the five-year window, FCF Margin soared 5835 bps in 2023 and tumbled 9594 bps in 2026, its largest moves.
- Year by year, FCF Margin stood at 85.34% in 2022, then surged by 60 bps to 34.47% in 2023, then soared by 63 bps to 12.82% in 2024, then tumbled by 32 bps to 16.95% in 2025, then tumbled by 30 bps to 22.1% in 2026.
- Per Business Quant, the three latest PTCT FCF Margin figures stand at 22.1% (Q1 2026), 16.95% (Q4 2025), and 33.05% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn | -22.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.10% |
| Dec 31, 2025 | -16.95% |
| Sep 30, 2025 | -33.05% |
| Jun 30, 2025 | -33.35% |
| Mar 31, 2025 | 73.84% |
| Dec 31, 2024 | -12.82% |
| Sep 30, 2024 | -39.39% |
| Mar 31, 2024 | 29.11% |
| Dec 31, 2023 | -34.47% |
| Sep 30, 2023 | -10.62% |
| Jun 30, 2023 | -14.32% |
| Mar 31, 2023 | -13.39% |
| Dec 31, 2022 | -85.34% |
| Sep 30, 2022 | -20.00% |
| Jun 30, 2022 | -38.63% |
| Mar 31, 2022 | -71.75% |
| Dec 31, 2021 | -46.94% |
| Sep 30, 2021 | -41.11% |
| Jun 30, 2021 | -33.53% |
| Mar 31, 2021 | -89.73% |